IRVINGTON, N.Y., May 6, 2013 /PRNewswire/ -- In recognition of Melanoma Monday ® and National Melanoma/Skin Cancer Detection & Prevention Month ™, MELA Sciences, Inc. (NASDAQ: MELA) visited the NASDAQ MarketSite in Times Square today to ring the Opening Bell and sponsor free skin cancer checks.
To view the multimedia assets associated with this release, please click: http://www.multivu.com/mnr/61584-mela-sciences-rings-opening-bell-awareness-melanoma-detection-prevention
"We're here today to highlight the importance of skin exams as a critical part of an overall commitment to skin cancer prevention," said Dr. Joseph Gulfo, President and CEO of MELA Sciences, Inc. "We are proud that our advanced melanoma detection technology is helping dermatologists nationwide address this public health crisis."One American dies every hour from melanoma, the most deadly skin cancer. MELA Sciences, Inc. is the pioneer company behind MelaFind ®, the first and only FDA-approved diagnostic tool that helps dermatologists detect melanoma at its most curable stage. MelaFind ® was approved by the U.S. Food & Drug Administration (FDA) in Fall 2011, and since then has strategically rolled out the technology to dermatology practices across the country. Joining Dr. Gulfo in the Opening Bell ceremony were Gary Goldenberg, MD, Assistant Professor of Dermatology and Pathology at The Mount Sinai School of Medicine, NY; Mark S. Nestor, MD, PhD, Voluntary Associate Professor of the Department of Dermatology and Cutaneous Surgery at the University Of Miami Leonard Miller School Of Medicine, and the Director of the Center for Cosmetic Enhancement and the Center for Clinical and Cosmetic Research in Aventura, Florida; and Claudia Beqaj, Director of Commercialization, MELA Sciences, Inc. "Prevention and early detection are the most effective ways to fight the melanoma epidemic," said Dr. Goldenberg. "Broad-spectrum sunscreens and safe sun practices are the first line of defense, along with regular skin exams. Once patients are in the office, advanced tools like MelaFind ® and dermoscopy help us better evaluate atypical moles to selectively determine which may need to be biopsied." "Melanoma detection starts with the patient," said Dr. Nestor. "A simple 5 minute skin exam can be the difference between life and death. So, we encourage patients to call their dermatologists and schedule an annual skin exam today."
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts